CIBC Private Wealth Group
RDHL

CIBC Private Wealth Group’s Redhill Biopharma RDHL Stock Holding History

CIBC Private Wealth Group’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12
Closed -$80K – 998
2020
Q3 		$80K Buy
+12
New +$98.4K ﹤0.01% 861
2020
Q2 		– Sell
-12
Closed -$54K – 762
2020
Q1 		$54K Buy
+12
New +$60K ﹤0.01% 828

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CIBC Private Wealth Group's RDHL Position: Q4 2020 in Review

CIBC Private Wealth Group sold out of Redhill Biopharma (RDHL) in Q4 2020, closing a stake of 12 shares — an estimated $80K sold.

CIBC Private Wealth Group first reported a position in RDHL in Q1 2020 and held it in 2 quarters. The position peaked at $80K in Q3 2020. 52 funds tracked by Wall St. Rank hold RDHL as of Q4 2020.

  • CIBC Private Wealth Group reported no remaining Redhill Biopharma position as of Q4 2020 after selling out during the quarter.
  • CIBC Private Wealth Group sold 12 Redhill Biopharma shares in Q4 2020, an estimated $80K.
  • CIBC Private Wealth Group first reported a position in Redhill Biopharma in Q1 2020 and held it in 2 quarters.
  • CIBC Private Wealth Group's Redhill Biopharma position peaked at $80K in Q3 2020.
  • 52 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2020.

Based on CIBC Private Wealth Group's 13F filing for Q4 2020, filed 12 Feb 2021.